Letermovir Injection and Trastuzumab and Hyaluronidase
Determining the interaction of Letermovir Injection and Trastuzumab and Hyaluronidase and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: letermovir
Brand name: Prevymis
Synonyms: Letermovir (oral/injection), Letermovir
Generic Name: hyaluronidase / trastuzumab
Brand name: Herceptin Hylecta
Synonyms: Hyaluronidase and trastuzumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Letermovir Injection-Trastuzumab Injection (Intravenous)
- Letermovir Injection-Trastuzumab Intravenous
- Letermovir Injection-Trastuzumab-anns
- Letermovir Injection-Trastuzumab-dkst
- Letermovir Injection-Trastuzumab-dkst Intravenous
- Letermovir Injection-Trasylol
- Trastuzumab and Hyaluronidase-Letermovir Intravenous
- Trastuzumab and Hyaluronidase-Letermovir oral/injection
- Trastuzumab and Hyaluronidase-Letermovir Tablets
- Trastuzumab and Hyaluronidase-Letrozole
- Trastuzumab and Hyaluronidase-Letrozole and ribociclib
- Trastuzumab and Hyaluronidase-Leucovorin